Investor Relations

Investor Relations

Mylan Inc., which provides products to customers in more than 150 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies.

Recent Releases

May 14, 2012
Mylan Specialty L.P. Commemorates 15th Annual Food Allergy Awareness Week

May 11, 2012
Mylan Launches Generic Lipitor® in Five European Countries

View all releases »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
Mylan Inc. (NASDAQ: MYL)
Price: 21.28
Change: + 0.06
Day High: 21.77
Day Low: 21.15
Volume: 8,266,100
Delayed at least 20 minutes.
Provided by eSignal.